|
|
|
|
|
|||||||
|
Session 98
Poster Session
Neuropathogenesis: Effects of Therapy 4:30-6:30 pm 4E-F |
to view the poster for an abstract.| 744-W. | Targeting Potential CNS Reservoirs of HIV-1: Inhibition of HIV-1 by SV(HIV-LTR)IFN S. Calarota*, P. Cordelier, R. J. Pomerantz, and D. Strayer Jefferson Med. Coll., Thomas Jefferson Univ., Philadelphia, PA
| ||
| 745-W. | Growth Hormone Is Neuroprotective in Vitro and in Vivo during HIV-1 Infection C. Silva, K. Zhang, J. B. Johnston, M. J. Gill, and C. Power* Univ. of Calgary, Alberta, Canada
| ||
| 746-W. | CSF HIV RNA and CNS Penetrating Antiretroviral Regimens K. Robertson*, S. A. Fiscus, W. Robertson, R. Meeker, and C. Hall Univ. of North Carolina, Chapel Hill
| ||
| 747-W. | Changes in CSF and Plasma HIV-1 RNA and in Cognition after Starting Potent Antiretroviral Therapy (ARV) Including a Protease Inhibitor (PI): Follow-Up Analyses C. M. Marra*, D. Lockhart, J. Zunt, M. Perrin, R. W. Coombs, and A. C. Collier Univ. of Washington, Seattle
| ||
| 748-W. | HIV Infection and Methamphetamine (Meth) Use Modulate Immune Markers in Cerebrospinal Fluid (CSF) S. Letendre*, R. J. Ellis, J. Zimmerman, J. McCutchan, T. Marcotte, and I. Grant Univ. of California, San Diego
|
